+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmaceutical Manufacturing Market - Global Forecast 2026-2032- Product Image
Pharmaceutical Manufacturing Market - Global Forecast 2026-2032- Product Image
Sale

Pharmaceutical Manufacturing Market - Global Forecast 2026-2032

  • Report

  • 191 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5896347
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Pharmaceutical Manufacturing Market is projected to reach USD 785.42 Billion in 2026. It is expected to continue growing at a CAGR of 7.90%, reaching USD 1.24 Trillion by 2032.

Pharmaceutical manufacturing is moving from capacity-led production to science-led, digitally controlled, and compliance-centered operations. Growth is being shaped by biologics, sterile injectables, high-potency APIs, continuous manufacturing, personalized therapies, and resilient pharmaceutical supply chains.

Verified signals from FDA, EMA, WHO, ICH, and public regulatory disclosures show that GMP compliance, quality assurance, traceability, data integrity, and speed-to-market now define competitive advantage across drug substance and drug product manufacturing.

Transformative Shifts in the Manufacturing Landscape

The pharmaceutical manufacturing landscape is shifting as manufacturers modernize legacy batch systems, strengthen supplier qualification, improve contamination control strategies, and adopt advanced process analytical technology. Revised EU GMP Annex 1, ICH Q9(R1), ICH Q10, and global serialization requirements have increased expectations for sterility assurance, risk management, and end-to-end product visibility.

At the same time, demand for biologics, oncology therapies, vaccines, orphan drugs, and specialty medicines is expanding the need for flexible facilities, aseptic fill-finish capacity, cold chain readiness, and CDMO partnerships supported by validated automation, electronic batch records, and compliant digital quality systems.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a practical layer across pharmaceutical manufacturing, especially in deviation detection, predictive maintenance, visual inspection, formulation development, batch record review, process optimization, demand sensing, and supply planning. AI supports faster decisions when integrated with validated data, electronic quality management systems, manufacturing execution systems, and GMP controls.

The cumulative impact is improved right-first-time performance, fewer unplanned shutdowns, stronger process understanding, and earlier detection of quality signals. However, regulated AI adoption requires explainability, audit trails, cybersecurity controls, model governance, human oversight, and alignment with FDA, EMA, ICH, data integrity principles, and GAMP 5 expectations.

Key Regional Insights: Asia-Pacific, North America, Europe, Latin America, Middle East, and Africa

Asia-Pacific is strengthening its pharmaceutical manufacturing position through large-scale API production, biosimilar investment, vaccine manufacturing, and expanding domestic healthcare demand, led by China, India, Japan, South Korea, Australia, and ASEAN economies. Public policy support, skilled scientific labor, and rising regulatory maturity are encouraging more complex drug substance and drug product production across the region.

North America remains a high-value hub for innovation, biologics, sterile injectables, advanced therapies, continuous manufacturing, and FDA-regulated quality systems, while Europe benefits from strong EMA oversight, mature GMP infrastructure, serialization compliance, and specialty drug production. Latin America is improving local manufacturing for essential medicines, vaccines, generics, and packaging to strengthen medicine access and reduce import dependency. The Middle East is investing in healthcare localization, procurement security, and industrial diversification, while Africa is prioritizing access, technology transfer, regional production resilience, and vaccine manufacturing capacity under public health and development initiatives.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN is becoming more relevant for pharmaceutical packaging, generics, contract manufacturing, and regional supply diversification, supported by healthcare expansion, regulatory cooperation, and demand for affordable medicines. The GCC is using national industrial strategies to localize medicines, vaccines, fill-finish operations, and biologics-adjacent capabilities while improving procurement resilience and healthcare security.

The European Union remains a regulatory benchmark for GMP, pharmacovigilance, clinical quality standards, and serialization, influencing global compliance expectations. BRICS markets offer scale, API depth, generics production, expanding biologics demand, and policy support for domestic manufacturing. G7 and NATO countries increasingly emphasize supply security, reshoring of critical medicines, advanced manufacturing technologies, cybersecurity, and protection of essential pharmaceutical supply chains.

Key Country Insights Across Major Pharmaceutical Manufacturing Markets

The United States leads in FDA-regulated innovation, biologics, cell and gene therapy, sterile injectables, continuous manufacturing, and CDMO depth, while Canada supports advanced therapies, vaccines, clinical-to-commercial manufacturing, and quality-driven pharmaceutical production. Mexico and Brazil are important for regional generics, packaging, access-driven production, and supply support across the Americas.

The United Kingdom, Germany, France, Italy, and Spain anchor Europe’s high-quality pharmaceutical manufacturing base through advanced GMP capabilities, specialty medicine production, biologics investment, and established export networks, while Russia emphasizes domestic supply resilience and localization of essential medicines. China and India dominate scale-sensitive API, intermediates, and generics capacity, supported by large supplier ecosystems and expanding regulatory capabilities. Japan and South Korea lead in quality-intensive production, biologics, vaccines, and advanced manufacturing, while Australia supports specialty, clinical, biotechnology, and regional manufacturing networks aligned with strict quality standards.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize validated digital transformation, quality-by-design implementation, contamination control, supplier risk mapping, and dual-sourcing for critical APIs, excipients, single-use components, and packaging materials. Investment decisions should favor flexible, modular, and energy-efficient facilities that can support biologics, sterile products, high-potency compounds, vaccines, and complex generics.

Executives should build AI governance frameworks, strengthen data integrity programs, improve cyber resilience, and align manufacturing strategy with evolving FDA, EMA, WHO, PIC/S, and ICH expectations. Leaders should also improve scenario planning for medicine shortages, qualify strategic suppliers, enhance workforce training, and integrate sustainability metrics into facility design and process optimization.

Research Methodology

This executive summary is based on structured secondary research using regulatory guidance, inspection and compliance references, public filings, government health data, trade sources, scientific literature, pharmacopeial references, and recognized industry publications. Sources include FDA, EMA, WHO, ICH, OECD, World Bank, UN trade datasets, national health agencies, and public company disclosures.

Insights were validated through triangulation across regulatory, operational, and commercial indicators, with emphasis on manufacturing capacity signals, GMP expectations, supply chain risk, regional production policy, technology adoption trends, quality system maturity, and public health priorities. The analysis avoids market sizing, market share, and forecasting to focus on verified structural and operational developments.

Conclusion

Pharmaceutical manufacturing is entering a more connected, regulated, and technology-enabled phase. Companies that combine scientific rigor with resilient operations will be best positioned to address medicine shortages, compliance pressure, cost control, sustainability expectations, and demand for complex therapies.

Sustainable advantage will depend on trusted quality systems, AI-ready data, regional supply strategies, validated automation, supplier resilience, and disciplined compliance execution across global pharmaceutical manufacturing networks.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Pharmaceutical Manufacturing Market, by Drug Type
7.1. Introduction
7.2. Biosimilars
7.3. Branded Drugs
7.4. Generic Drugs
8. Pharmaceutical Manufacturing Market, by Molecule Type
8.1. Introduction
8.2. Large Molecule Drugs
8.3. Small Molecule Drugs
9. Pharmaceutical Manufacturing Market, by Dosage Form
9.1. Introduction
9.2. Liquid Dosage Forms
9.2.1. Solution
9.2.2. Suspension
9.3. Parenteral Dosage Forms
9.3.1. Infusion Forms
9.3.2. Injectable Forms
9.4. Solid Dosage Forms
9.4.1. Capsule
9.4.2. Powder
9.4.3. Tablet
9.5. Topical
9.5.1. Ointments
9.5.2. Creams
9.5.3. Gels
9.5.4. Lotions
9.6. Inhalation
9.7. Transdermal Patches
9.8. Ophthalmic Solutions
10. Pharmaceutical Manufacturing Market, by Manufacturing Stage
10.1. Introduction
10.2. API Manufacturing
10.3. Formulation Manufacturing
10.4. Packaging & Labelling
11. Pharmaceutical Manufacturing Market, by Manufacturing Technology
11.1. Introduction
11.2. Batch Manufacturing
11.3. Continuous Manufacturing
11.4. Single-Use Technology
12. Pharmaceutical Manufacturing Market, by Therapeutic Area
12.1. Introduction
12.2. Cardiovascular
12.3. Gastroenterology
12.4. Immunology
12.5. Infectious Diseases
12.6. Neurology
12.7. Oncology
12.8. Respiratory
13. Pharmaceutical Manufacturing Market, by Age Group
13.1. Introduction
13.2. Children & Adolescents
13.3. Adults
13.4. Geriatric
14. Pharmaceutical Manufacturing Market, by Distribution
14.1. Introduction
14.2. Direct Sales
14.3. Wholesale / Distributors
14.4. Retail Pharmacy
14.5. Online / E-Commerce Pharmacies
14.6. Hospital Pharmacy Distribution
15. Pharmaceutical Manufacturing Market, by Region
15.1. Asia-Pacific
15.2. Europe
15.3. North America
15.4. Latin America
15.5. Africa
15.6. Middle East
16. Pharmaceutical Manufacturing Market, by Group
16.1. NATO
16.2. G7
16.3. European Union
16.4. BRICS
16.5. ASEAN
16.6. GCC
17. Pharmaceutical Manufacturing Market, by Country
17.1. United States
17.2. China
17.3. Germany
17.4. Japan
17.5. India
17.6. United Kingdom
17.7. France
17.8. Canada
17.9. Italy
17.10. Australia
17.11. South Korea
17.12. Brazil
17.13. Mexico
17.14. Russia
17.15. Spain
18. Competitive Landscape
18.1. Market Share Analysis, 2025
18.2. FPNV Positioning Matrix, 2025
18.3. Market Concentration Analysis, 2025
18.3.1. Concentration Ratio (CR)
18.3.2. Herfindahl Hirschman Index (HHI)
18.4. Recent Developments & Impact Analysis, 2025
18.5. Product Portfolio Analysis, 2025
18.6. Benchmarking Analysis, 2025
19. Company Profiles
19.1. Abbott Laboratories
19.2. AbbVie Inc.
19.3. Alkem Laboratories Ltd.
19.4. Amgen Inc.
19.5. Astellas Pharma Inc.
19.6. AstraZeneca plc
19.7. Aurobindo Pharma Ltd.
19.8. Baxter International Inc.
19.9. Bayer AG
19.10. Biogen Inc.
19.11. Boehringer Ingelheim GmbH
19.12. Bristol-Myers Squibb Company
19.13. Cipla Ltd.
19.14. Croda International Plc
19.15. CSL Limited
19.16. Divi’s Laboratories Ltd.
19.17. Dr. Reddy’s Laboratories Ltd.
19.18. Eli Lilly and Company
19.19. F. Hoffmann-La Roche Ltd.
19.20. Gilead Sciences, Inc.
19.21. GlaxoSmithKline plc
19.22. Johnson & Johnson Services, inc.
19.23. Lupin Ltd.
19.24. Mankind Pharma Ltd.
19.25. Merck KGaA
19.26. Novartis AG
19.27. Novo Nordisk A/S
19.28. Pfizer Inc.
19.29. Sanofi S.A.
19.30. Sun Pharmaceutical Industries Limited
19.31. Takeda Pharmaceutical Company Ltd.
19.32. Teva Pharmaceutical Industries Ltd.
19.33. Thermo Fisher Scientific Inc.
19.34. Torrent Pharmaceuticals Ltd.
19.35. Viatris Inc.
19.36. Zydus Lifesciences Ltd.
List of Figures
FIGURE 1. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2025 VS 2032 (%)
FIGURE 11. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 15. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2032 (%)
FIGURE 17. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 23. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 25. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 27. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 29. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL BIOSIMILARS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL BIOSIMILARS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL BIOSIMILARS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL BRANDED DRUGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL BRANDED DRUGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL BRANDED DRUGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL GENERIC DRUGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL GENERIC DRUGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL GENERIC DRUGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL LARGE MOLECULE DRUGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL LARGE MOLECULE DRUGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL LARGE MOLECULE DRUGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL SMALL MOLECULE DRUGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL SMALL MOLECULE DRUGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL SMALL MOLECULE DRUGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL LIQUID DOSAGE FORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL LIQUID DOSAGE FORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL LIQUID DOSAGE FORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL SOLUTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL SOLUTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL SOLUTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL SUSPENSION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL SUSPENSION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL SUSPENSION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL PARENTERAL DOSAGE FORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL PARENTERAL DOSAGE FORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL PARENTERAL DOSAGE FORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL INFUSION FORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL INFUSION FORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL INFUSION FORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL INJECTABLE FORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL INJECTABLE FORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL INJECTABLE FORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL SOLID DOSAGE FORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL SOLID DOSAGE FORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL SOLID DOSAGE FORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL CAPSULE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL CAPSULE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL CAPSULE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL POWDER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL POWDER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL POWDER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL TABLET MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL TABLET MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL TABLET MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL OINTMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL OINTMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL OINTMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL CREAMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL CREAMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL CREAMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL GELS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL GELS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL GELS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL LOTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL LOTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL LOTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL INHALATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL INHALATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL INHALATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL OPHTHALMIC SOLUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL OPHTHALMIC SOLUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL OPHTHALMIC SOLUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL API MANUFACTURING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL API MANUFACTURING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL API MANUFACTURING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL FORMULATION MANUFACTURING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL FORMULATION MANUFACTURING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL FORMULATION MANUFACTURING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL PACKAGING & LABELLING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL PACKAGING & LABELLING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL PACKAGING & LABELLING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL BATCH MANUFACTURING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL BATCH MANUFACTURING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL BATCH MANUFACTURING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL CONTINUOUS MANUFACTURING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL CONTINUOUS MANUFACTURING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL SINGLE-USE TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL SINGLE-USE TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL SINGLE-USE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL CARDIOVASCULAR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL CARDIOVASCULAR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL CARDIOVASCULAR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL GASTROENTEROLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL GASTROENTEROLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL GASTROENTEROLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL IMMUNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL IMMUNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL IMMUNOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL NEUROLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL NEUROLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL NEUROLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL RESPIRATORY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL RESPIRATORY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL RESPIRATORY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL CHILDREN & ADOLESCENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL CHILDREN & ADOLESCENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL CHILDREN & ADOLESCENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL ADULTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL ADULTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL ADULTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL WHOLESALE / DISTRIBUTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL WHOLESALE / DISTRIBUTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL WHOLESALE / DISTRIBUTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL RETAIL PHARMACY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL RETAIL PHARMACY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL RETAIL PHARMACY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL ONLINE / E-COMMERCE PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL ONLINE / E-COMMERCE PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL ONLINE / E-COMMERCE PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL HOSPITAL PHARMACY DISTRIBUTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL HOSPITAL PHARMACY DISTRIBUTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL HOSPITAL PHARMACY DISTRIBUTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2017-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2017-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2017-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 157. EUROPE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 158. EUROPE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2017-2032 (USD MILLION)
TABLE 159. EUROPE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 160. EUROPE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2017-2032 (USD MILLION)
TABLE 161. EUROPE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 162. EUROPE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 163. EUROPE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 164. EUROPE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 165. EUROPE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2017-2032 (USD MILLION)
TABLE 166. EUROPE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 167. EUROPE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 168. EUROPE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 169. EUROPE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 170. NORTH AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 171. NORTH AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2017-2032 (USD MILLION)
TABLE 172. NORTH AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 173. NORTH AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2017-2032 (USD MILLION)
TABLE 174. NORTH AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 175. NORTH AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 176. NORTH AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 177. NORTH AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 178. NORTH AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2017-2032 (USD MILLION)
TABLE 179. NORTH AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 180. NORTH AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 181. NORTH AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 182. NORTH AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 183. LATIN AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 184. LATIN AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2017-2032 (USD MILLION)
TABLE 185. LATIN AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 186. LATIN AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2017-2032 (USD MILLION)
TABLE 187. LATIN AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 188. LATIN AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 189. LATIN AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 190. LATIN AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 191. LATIN AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2017-2032 (USD MILLION)
TABLE 192. LATIN AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 193. LATIN AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 194. LATIN AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 195. LATIN AMERICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 196. AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 197. AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2017-2032 (USD MILLION)
TABLE 198. AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 199. AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2017-2032 (USD MILLION)
TABLE 200. AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 201. AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 202. AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 203. AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 204. AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2017-2032 (USD MILLION)
TABLE 205. AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 206. AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 207. AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 208. AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 209. MIDDLE EAST PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 210. MIDDLE EAST PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2017-2032 (USD MILLION)
TABLE 211. MIDDLE EAST PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 212. MIDDLE EAST PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2017-2032 (USD MILLION)
TABLE 213. MIDDLE EAST PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 214. MIDDLE EAST PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 215. MIDDLE EAST PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 216. MIDDLE EAST PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 217. MIDDLE EAST PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2017-2032 (USD MILLION)
TABLE 218. MIDDLE EAST PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 219. MIDDLE EAST PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 220. MIDDLE EAST PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 221. MIDDLE EAST PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 222. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 223. NATO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 224. NATO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2017-2032 (USD MILLION)
TABLE 225. NATO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 226. NATO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2017-2032 (USD MILLION)
TABLE 227. NATO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 228. NATO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 229. NATO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 230. NATO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 231. NATO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2017-2032 (USD MILLION)
TABLE 232. NATO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 233. NATO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 234. NATO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 235. NATO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 236. G7 PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 237. G7 PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2017-2032 (USD MILLION)
TABLE 238. G7 PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 239. G7 PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2017-2032 (USD MILLION)
TABLE 240. G7 PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 241. G7 PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 242. G7 PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 243. G7 PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 244. G7 PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2017-2032 (USD MILLION)
TABLE 245. G7 PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 246. G7 PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 247. G7 PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 248. G7 PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 249. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 250. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2017-2032 (USD MILLION)
TABLE 251. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 252. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2017-2032 (USD MILLION)
TABLE 253. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 254. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 255. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 256. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 257. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2017-2032 (USD MILLION)
TABLE 258. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 259. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 260. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 261. EUROPEAN UNION PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 262. BRICS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 263. BRICS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2017-2032 (USD MILLION)
TABLE 264. BRICS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 265. BRICS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2017-2032 (USD MILLION)
TABLE 266. BRICS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 267. BRICS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 268. BRICS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 269. BRICS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 270. BRICS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2017-2032 (USD MILLION)
TABLE 271. BRICS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 272. BRICS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 273. BRICS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 274. BRICS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 275. ASEAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 276. ASEAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2017-2032 (USD MILLION)
TABLE 277. ASEAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 278. ASEAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2017-2032 (USD MILLION)
TABLE 279. ASEAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 280. ASEAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 281. ASEAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 282. ASEAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 283. ASEAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2017-2032 (USD MILLION)
TABLE 284. ASEAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 285. ASEAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 286. ASEAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 287. ASEAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 288. GCC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 289. GCC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2017-2032 (USD MILLION)
TABLE 290. GCC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 291. GCC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2017-2032 (USD MILLION)
TABLE 292. GCC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 293. GCC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 294. GCC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 295. GCC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 296. GCC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2017-2032 (USD MILLION)
TABLE 297. GCC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 298. GCC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 299. GCC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 300. GCC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 301. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 302. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 303. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2017-2032 (USD MILLION)
TABLE 304. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 305. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2017-2032 (USD MILLION)
TABLE 306. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 307. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 308. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 309. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 310. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2017-2032 (USD MILLION)
TABLE 311. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 312. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 313. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 314. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 315. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 316. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2017-2032 (USD MILLION)
TABLE 317. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 318. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2017-2032 (USD MILLION)
TABLE 319. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 320. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 321. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 322. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 323. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2017-2032 (USD MILLION)
TABLE 324. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 325. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 326. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 327. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 328. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 329. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2017-2032 (USD MILLION)
TABLE 330. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 331. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2017-2032 (USD MILLION)
TABLE 332. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 333. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 334. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2017-2032 (USD MILLION)
TABLE 335. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 336. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2017-2032 (USD MILLION)
TABLE 337. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 338. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2017-2032 (USD MILLION)
TABLE 339. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 340. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2017-2032 (USD MILLION)
TABLE 341. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 342. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2017-2032 (USD MILLION)
TABLE 343. JAPAN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2017-2032 (USD MILLION)
TABLE 344. JAPAN PHARMACEUTICAL MANUFACTURING MAR

Companies Mentioned

  • Abbott Laboratories
  • AbbVie Inc.
  • Alkem Laboratories Ltd.
  • Amgen Inc.
  • Astellas Pharma Inc.
  • AstraZeneca plc
  • Aurobindo Pharma Ltd.
  • Baxter International Inc.
  • Bayer AG
  • Biogen Inc.
  • Boehringer Ingelheim GmbH
  • Bristol‑Myers Squibb Company
  • Cipla Ltd.
  • Croda International Plc
  • CSL Limited
  • Divi’s Laboratories Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, inc.
  • Lupin Ltd.
  • Mankind Pharma Ltd.
  • Merck KGaA
  • Novartis AG
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Limited
  • Takeda Pharmaceutical Company Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Thermo Fisher Scientific Inc.
  • Torrent Pharmaceuticals Ltd.
  • Viatris Inc.
  • Zydus Lifesciences Ltd.

Table Information

Report AttributeDetails
No. of Pages191
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 785.42 Billion
Forecasted Market Value ( USD ) by 2032 $ 1240 Billion
Compound Annual Growth Rate7.9%
Regions CoveredGlobal
No. of Companies Mentioned36

Related Topics

Related Reports

Pharmaceutical Manufacturing Market Size, Share & Trends Analysis Report by Route of Administration, Molecule Type, Drug Development, Sales Channel, Therapy Area, Prescription, Age Group, Formulation, Region, and Growth Forecasts, 2026-2033 - Product Image

Pharmaceutical Manufacturing Market Size, Share & Trends Analysis Report by Route of Administration, Molecule Type, Drug Development, Sales Channel, Therapy Area, Prescription, Age Group, Formulation, Region, and Growth Forecasts, 2026-2033

  • Report
  • 90 Pages
  • Global
From
Pharmaceutical Contract Manufacturing Market - Global Forecast 2026-2032 - Product Image

Pharmaceutical Contract Manufacturing Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Formulation Development Outsourcing Market - Global Forecast 2026-2032 - Product Image

Formulation Development Outsourcing Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Pharmaceutical Manufacturing Equipment Market by Equipment Type, End Product, Technology - Global Forecast to 2032 - Product Image

Pharmaceutical Manufacturing Equipment Market by Equipment Type, End Product, Technology - Global Forecast to 2032

  • Report
  • 322 Pages
  • Global
From
High Potency API Contract Manufacturing - Global Strategic Business Report - Product Image

High Potency API Contract Manufacturing - Global Strategic Business Report

  • Report
  • 466 Pages
  • Global
From

About the Pharmaceutical Manufacturing Market

The Pharmaceutical Manufacturing market is composed of companies that produce drugs and other pharmaceutical products. These products are used to treat and prevent diseases, as well as to improve the quality of life. Pharmaceutical manufacturers are responsible for the research, development, production, and distribution of these products. They must adhere to strict regulations and standards to ensure the safety and efficacy of their products. The Pharmaceutical Manufacturing market is highly competitive, with many large companies vying for market share. Some of the major players in the market include Pfizer, Merck, Johnson & Johnson, Novartis, and GlaxoSmithKline. These companies are involved in the research, development, production, and distribution of pharmaceutical products. They are also involved in the marketing and promotion of their products. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.